Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
inflammatory5866 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A49841 | 35624731 | Antioxidants (Basel) | Administration of Glutaredoxin-1 Attenuates Liver Fibrosis Caused by Aging and Non-Alcoholic Steatohepatitis. | 2022 | Details |
| A49844 | 35623903 | Phytother Res | Zingiberaceae plants/curcumin consumption and multiple health outcomes: An umbrella review of systematic reviews and meta-analyses of randomized controlled trials in humans. | 2022 | Details |
| A49846 | 35623174 | Biomed Pharmacother | Corydalis saxicola Bunting Total Alkaloids ameliorate diet-induced non-alcoholic steatohepatitis by regulating hepatic PI3K/Akt and TLR4/NF-κB pathways in mice. | 2022 | Details |
| A49848 | 35621963 | Mar Drugs | Monkfish Peptides Mitigate High Fat Diet-Induced Hepatic Steatosis in Mice. | 2022 | Details |
| A49856 | 35617696 | Expert Rev Gastroenterol Hepatol | Efficiency of ursodeoxycholic acid for the treatment of nonalcoholic steatohepatitis: A systematic review and meta-analysis. | 2022 | Details |
| A49864 | 35614939 | Front Pharmacol | Obeticholic Acid Induces Hepatoxicity Via FXR in the NAFLD Mice. | 2022 | Details |
| A49882 | 35609858 | J Nutr Biochem | Phloretin mitigates oxidative injury, inflammation, and fibrogenic responses via restoration of autophagic flux in in vitro and preclinical models of NAFLD. | 2022 | Details |
| A49885 | 35608965 | Eur J Neurol | Nonalcoholic fatty liver disease, serum cytokines, and dementia among rural-dwelling older adults in China: A population-based study. | 2022 | Details |
| A49898 | 35604436 | Rheumatol Int | Treatment of rheumatoid arthritis with conventional, targeted and biological disease-modifying antirheumatic drugs in the setting of liver injury and non-alcoholic fatty liver disease. | 2022 | Details |
| A49901 | 35603482 | Hepatology | PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interference. | 2022 | Details |
| A49903 | 35603224 | Front Immunol | Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A49904 | 35603209 | Front Immunol | Liver Stiffness by Transient Elastography Correlates With Degree of Portal Hypertension in Common Variable Immunodeficiency Patients With Nodular Regenerative Hyperplasia. | 2022 | Details |
| A49905 | 35602098 | Oxid Med Cell Longev | A Molecular Insight into the Role of Antioxidants in Nonalcoholic Fatty Liver Diseases. | 2022 | Details |
| A49907 | 35600209 | Can J Gastroenterol Hepatol | Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease. | 2022 | Details |
| A49915 | 35598211 | Orv Hetil | A nem alkoholos zsírmájbetegség és a 2-es típusú cukorbetegség. | 2022 | Details |
| A49931 | 35590219 | Med (N Y) | Inhibition of ketohexokinase in adults with NAFLD reduces liver fat and inflammatory markers: A randomized phase 2 trial. | 2021 | Details |
| A49944 | 35586049 | Front Pharmacol | Artemether Ameliorates Non-Alcoholic Steatohepatitis by Repressing Lipogenesis, Inflammation, and Fibrosis in Mice. | 2022 | Details |
| A49945 | 35586044 | Front Pharmacol | Protective Effects of Tiaoganquzhi Decoction in Treating inflammatory Injury of Nonalcoholic Fatty liver Disease by Promoting CGI-58 and Inhibiting Expression of NLRP3 Inflammasome. | 2022 | Details |
| A49953 | 35584453 | Braz J Med Biol Res | The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in rats. | 2022 | Details |
| A49954 | 35583582 | Chin J Integr Med | Molecular Mechanism of Polysaccharides Extracted from Chinese Medicine Targeting Gut Microbiota for Promoting Health. | 2022 | Details |
| A49971 | 35578028 | Inflamm Res | Prolonged effects of DPP-4 inhibitors on steato-hepatitic changes in Sprague-Dawley rats fed a high-cholesterol diet. | 2022 | Details |
| A49983 | 35572532 | Front Immunol | Reactive Oxygen Species Induce Fatty Liver and Ischemia-Reperfusion Injury by Promoting Inflammation and Cell Death. | 2022 | Details |
| A49991 | 35569768 | Gene | White tea alleviates non-alcoholic fatty liver disease by regulating energy expenditure and lipid metabolism. | 2022 | Details |
| A49992 | 35569762 | Drug Discov Today | Impact of fenofibrate on NAFLD/NASH: A genetic perspective. | 2022 | Details |
| A49996 | 35568098 | J Nutr Biochem | Indole supplementation ameliorates MCD-induced NASH in mice. | 2022 | Details |
| A49997 | 35567872 | Complement Ther Clin Pract | The effect of nigella sativa supplementation on cardiometabolic outcomes in patients with non-alcoholic fatty liver: A randomized double-blind, placebo-controlled trial. | 2022 | Details |
| A49998 | 35567505 | FASEB J | Mesencephalic astrocyte-derived neurotrophic factor alleviates non-alcoholic steatohepatitis induced by Western diet in mice. | 2022 | Details |
| A50000 | 35566749 | J Clin Med | Hepatic Steatosis and Fibrosis in Chronic Inflammatory Bowel Disease. | 2022 | Details |
| A50003 | 35565930 | Nutrients | Bifidobacterium animalis ssp. lactis MG741 Reduces Body Weight and Ameliorates Nonalcoholic Fatty Liver Disease via Improving the Gut Permeability and Amelioration of Inflammatory Cytokines. | 2022 | Details |
| A50007 | 35565666 | Nutrients | Myristica fragrans Extract Regulates Gut Microbes and Metabolites to Attenuate Hepatic Inflammation and Lipid Metabolism Disorders via the AhR-FAS and NF-κB Signaling Pathways in Mice with Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50009 | 35563780 | Cells | Mitochondria and the NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis. | 2022 | Details |
| A50015 | 35563377 | Int J Mol Sci | Regulatory Roles of Caspase-11 Non-Canonical Inflammasome in Inflammatory Liver Diseases. | 2022 | Details |
| A50040 | 35550529 | Biomed Pharmacother | The anti-inflammatory effect of Pien Tze Huang in non-alcoholic fatty liver disease. | 2022 | Details |
| A50056 | 35543143 | Food Funct | Co-interventions with Clostridium butyricum and soluble dietary fiber targeting the gut microbiota improve MAFLD via the Acly/Nrf2/NF-κB signaling pathway. | 2022 | Details |
| A50069 | 35536225 | J Agric Food Chem | Caffeine Ameliorates AKT-Driven Nonalcoholic Steatohepatitis by Suppressing De Novo Lipogenesis and MyD88 Palmitoylation. | 2022 | Details |
| A50080 | 35534573 | Nat Rev Endocrinol | Macrophage functional diversity in NAFLD - more than inflammation. | 2022 | Details |
| A50085 | 35532955 | Metab Syndr Relat Disord | Nonalcoholic Fatty Liver Disease Patients Exhibit Reduced CD47 and Increased Sphingosine, Cholesterol, and Monocyte Chemoattractant Protein-1 Levels in the Erythrocyte Membranes. | 2022 | Details |
| A50090 | 35531696 | Zhongguo Zhong Yao Za Zhi | [Di'ao Xinxuekang alleviates non-alcoholic steatohepatitis in mice by up-regulating Nrf2/HO-1 signaling pathway]. | 2022 | Details |
| A50106 | 35525796 | Pathology | Prevalence and clinical significance of portal inflammation, portal plasma cells, interface hepatitis and biliary injury in liver biopsies from patients with non-alcoholic steatohepatitis. | 2022 | Details |
| A50110 | 35522866 | Wiad Lek | FEATURES OF INTESTINAL MICROBIOTA IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE: EFFECTS ON MARKERS OF INFLAMMATION AND HEPATIC STEATOSIS. | 2022 | Details |
| A50114 | 35518363 | Cureus | Whether Screening for Non-alcoholic Fatty Liver Disease in Patients With Psoriasis Is Necessary: A Pilot Quality Improvement Project. | 2022 | Details |
| A50115 | 35517895 | Adv Pharm Bull | Protective Role of trans-Chalcone against the Progression from Simple Steatosis to Non-alcoholic Steatohepatitis: Regulation of miR-122, 21, 34a, and 451. | 2021 | Details |
| A50118 | 35514751 | Front Med (Lausanne) | SPP1 and CXCL9 Promote Non-alcoholic Steatohepatitis Progression Based on Bioinformatics Analysis and Experimental Studies. | 2022 | Details |
| A50126 | 35510444 | Phys Act Nutr | Pharmacological systemic analysis of gardenia fructus against non-alcoholic fatty liver disease and validation of animal models. | 2022 | Details |
| A50127 | 35510379 | J Food Biochem | Major royal jelly proteins alleviate non-alcoholic fatty liver disease in mice model by regulating disordered metabolic pathways. | 2022 | Details |
| A50143 | 35504134 | Redox Biol | Overexpression of NAG-1/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation. | 2022 | Details |
| A50147 | 35503185 | Virchows Arch | Neutrophil extracellular traps enriched with IL-1β and IL-17A participate in the hepatic inflammatory process of patients with non-alcoholic steatohepatitis. | 2022 | Details |
| A50150 | 35503172 | Adv Exp Med Biol | De Novo Sphingolipid Biosynthesis in Atherosclerosis. | 2022 | Details |
| A50158 | 35500675 | Cell Mol Gastroenterol Hepatol | Macrophage-Specific SCAP Promotes Liver and Adipose Tissue Damage in a Lean NAFLD Model: Lean, Mean, Proinflammatory Machine. | 2022 | Details |
| A50164 | 35495903 | Front Nutr | Amino Acid and Fatty Acid Metabolism Disorders Trigger Oxidative Stress and Inflammatory Response in Excessive Dietary Valine-Induced NAFLD of Laying Hens. | 2022 | Details |
| A50180 | 35487948 | Sci Rep | Hibiscus sabdariffa extract improves hepatic steatosis, partially through IRS-1/Akt and Nrf2 signaling pathways in rats fed a high fat diet. | 2022 | Details |
| A50188 | 35485140 | Bioengineered | Livogrit Prevents Methionine-Cystine Deficiency Induced Nonalcoholic Steatohepatitis by Modulation of Steatosis and Oxidative Stress in Human Hepatocyte-Derived Spheroid and in Primary Rat Hepatocytes. | 2022 | Details |
| A50193 | 35483638 | J Control Release | Celastrol-loaded lactosylated albumin nanoparticles attenuate hepatic steatosis in non-alcoholic fatty liver disease. | 2022 | Details |
| A50197 | 35481220 | Exp Ther Med | Epigenetics in inflammatory liver diseases: A clinical perspective (Review). | 2022 | Details |
| A50198 | 35479741 | Front Nutr | Hepatoprotection of Probiotics Against Non-Alcoholic Fatty Liver Disease in vivo: A Systematic Review. | 2022 | Details |
| A50203 | 35477031 | Ann Hepatol | Non-invasive methods for iron overload evaluation in dysmetabolic patients. | 2022 | Details |
| A50205 | 35476028 | J Mol Med (Berl) | Receptor-interacting protein kinase-1 ablation in liver parenchymal cells promotes liver fibrosis in murine NASH without affecting other symptoms. | 2022 | Details |
| A50213 | 35471616 | Wien Klin Wochenschr | New inflammatory biomarkers (lymphocyte and monocyte percentage to high-density lipoprotein cholesterol ratio and lymphocyte to monocyte percentage ratio) and their association with some cardiometabolic diseases : Results from a large Kurdish cohort study in Iran. | 2022 | Details |
| A50219 | 35468693 | Front Biosci (Landmark Ed) | Quarter-Century Explorations of Bioactive Polyphenols: Diverse Health Benefits. | 2022 | Details |
| A50229 | 35464279 | Hepatobiliary Surg Nutr | A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation study. | 2022 | Details |
| A50234 | 35462859 | JHEP Rep | Epigenetics of alcohol-related liver diseases. | 2022 | Details |
| A50236 | 35462486 | Zhonghua Gan Zang Bing Za Zhi | [Bioinformatics screening and analysis of key differentially expressed genes characteristics in nonalcoholic fatty liver disease]. | 2022 | Details |
| A50250 | 35456053 | Cells | Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids. | 2022 | Details |
| A50266 | 35449483 | Mol Cell Biochem | Hepatocyte expressed chemerin-156 does not protect from experimental non-alcoholic steatohepatitis. | 2022 | Details |
| A50273 | 35447899 | Mar Drugs | Fucoxanthin Attenuates Free Fatty Acid-Induced Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism/Oxidative Stress/Inflammation via the AMPK/Nrf2/TLR4 Signaling Pathway. | 2022 | Details |
| A50274 | 35447548 | Biomed Pharmacother | Downregulation of hepatic fat accumulation, inflammation and fibrosis by nerolidol in purpose built western-diet-induced multiple-hit pathogenesis of NASH animal model. | 2022 | Details |
| A50290 | 35442594 | Int J Med Mushrooms | Meal Ingestion of Ceraceomyces tessulatus Strain BDM-X (Agaricomycetes) Protects against Nonalcoholic Steatohepatitis in Mice. | 2022 | Details |
| A50304 | 35437952 | EMBO Mol Med | When fat meets the gut-focus on intestinal lipid handling in metabolic health and disease. | 2022 | Details |
| A50306 | 35437549 | Food Funct | L-Methionine supplementation attenuates high-fat fructose diet-induced non-alcoholic steatohepatitis by modulating lipid metabolism, fibrosis, and inflammation in rats. | 2022 | Details |
| A50310 | 35436630 | Biochem Biophys Res Commun | Hydrochloride Berberine ameliorates alcohol-induced liver injury by regulating inflammation and lipid metabolism. | 2022 | Details |
| A50320 | 35434600 | Food Chem X | Kombucha - An ancient fermented beverage with desired bioactivities: A narrowed review. | 2022 | Details |
| A50323 | 35433771 | Front Med (Lausanne) | Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma. | 2022 | Details |
| A50360 | 35418153 | Diabetol Metab Syndr | Epigallocatechin-3-gallate ameliorates hepatic damages by relieve FGF21 resistance and promotion of FGF21-AMPK pathway in mice fed a high fat diet. | 2022 | Details |
| A50362 | 35417873 | Georgian Med News | HISTOLOGICAL AND HISTOCHEMICAL FEATURES OF LIVER AND LUNG TISSUE IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND OBESITY DEPENDING ON THE PRESENCE OF COMORBID CHRONIC OBSTRUCTIVE PULMONARY DISEASE. | 2022 | Details |
| A50367 | 35416190 | Food Funct | The effect of hydroxy citric acid supplementation with calorie-restricted diet on metabolic, atherogenic and inflammatory biomarkers in women with non-alcoholic fatty liver disease: a randomized controlled clinical trial. | 2022 | Details |
| A50370 | 35413806 | BMC Gastroenterol | Prevalence and predictors of non-alcoholic liver disease on MRI among patients with Crohn's disease. | 2022 | Details |
| A50373 | 35413066 | PLoS One | Anti-inflammatory function of apolipoprotein B-depleted plasma is impaired in non-alcoholic fatty liver disease. | 2022 | Details |
| A50386 | 35409028 | Int J Mol Sci | SGLT2 Inhibitors as the Most Promising Influencers on the Outcome of Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50391 | 35407014 | Foods | Tilapia-Head Chondroitin Sulfate Protects against Nonalcoholic Fatty Liver Disease via Modulating the Gut-Liver Axis in High-Fat-Diet-Fed C57BL/6 Mice. | 2022 | Details |
| A50396 | 35405948 | Nutrients | Do MAFLD Patients with Harmful Alcohol Consumption Have a Different Dietary Intake? | 2022 | Details |
| A50416 | 35399623 | Evid Based Complement Alternat Med | Er-Chen Decoction Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Rats through Remodeling Gut Microbiota and Regulating the Serum Metabolism. | 2022 | Details |
| A50418 | 35398611 | Biochem Biophys Res Commun | Abietic acid alleviates endoplasmic reticulum stress and lipid accumulation in human primary hepatocytes through the AMPK/ORP150 signaling. | 2022 | Details |
| A50423 | 35397399 | Eur J Med Chem | Synthesis of heterocyclic ring-fused analogs of HMG499 as novel degraders of HMG-CoA reductase that lower cholesterol. | 2022 | Details |
| A50428 | 35396090 | J Pediatr Surg | The preventive effect of recombinant human hepatocyte growth factor for hepatic steatosis in a rat model of short bowel syndrome. | 2022 | Details |
| A50442 | 35390440 | Food Chem Toxicol | Tectorigenin ameliorated high-fat diet-induced nonalcoholic fatty liver disease through anti-inflammation and modulating gut microbiota in mice. | 2022 | Details |
| A50448 | 35386695 | Front Immunol | Systemic Immune-Inflammation Index Is Associated With Increased Urinary Albumin Excretion: A Population-Based Study. | 2022 | Details |
| A50463 | 35381388 | Mol Metab | Proteomic analysis reveals exercise training induced remodelling of hepatokine secretion and uncovers syndecan-4 as a regulator of hepatic lipid metabolism. | 2022 | Details |
| A50469 | 35378172 | J Hepatol | Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD. | 2022 | Details |
| A50478 | 35370963 | Front Endocrinol (Lausanne) | The Mechanism Underlying the Influence of Indole-3-Propionic Acid: A Relevance to Metabolic Disorders. | 2022 | Details |
| A50482 | 35368864 | Oxid Med Cell Longev | The Imbalance of Mitochondrial Homeostasis of Peripheral Blood-Derived Macrophages Mediated by MAFLD May Impair the Walking Ability of Elderly Patients with Osteopenia. | 2022 | Details |
| A50485 | 35367665 | Cell Mol Gastroenterol Hepatol | Macrophage SCAP Contributes to Metaflammation and Lean NAFLD by Activating STING-NF-κB Signaling Pathway. | 2022 | Details |
| A50510 | 35358801 | Biomed Pharmacother | Bioinformatics study of the potential therapeutic effects of ginsenoside Rf in reversing nonalcoholic fatty liver disease. | 2022 | Details |
| A50511 | 35358477 | Biochem Pharmacol | Valdecoxib attenuates lipid-induced hepatic steatosis through autophagy-mediated suppression of endoplasmic reticulum stress. | 2022 | Details |
| A50517 | 35355551 | Front Endocrinol (Lausanne) | Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients - a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown. | 2022 | Details |
| A50520 | 35354841 | Sci Rep | Aerobic exercise promotes the expression of ATGL and attenuates inflammation to improve hepatic steatosis via lncRNA SRA. | 2022 | Details |
| A50534 | 35350750 | Front Pharmacol | The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment. | 2022 | Details |
| A50556 | 35343085 | Clin Transl Med | MD2 deficiency prevents high-fat diet-induced AMPK suppression and lipid accumulation through regulating TBK1 in non-alcoholic fatty liver disease. | 2022 | Details |
| A50557 | 35341816 | Environ Pollut | Early-life exposure to bisphenol A induces dysregulation of lipid homeostasis by the upregulation of SCD1 in male mice. | 2022 | Details |
| A50564 | 35338970 | Bioorg Chem | Dihydroartemisinin alleviates steatosis and inflammation in nonalcoholic steatohepatitis by decreasing endoplasmic reticulum stress and oxidative stress. | 2022 | Details |
| A50566 | 35338494 | J Food Biochem | Zingerone ameliorates non-alcoholic fatty liver disease in rats by activating AMPK. | 2022 | Details |